Epstein Secrets

Equity Change In Value 423,834.75 (70,000.00) 3,428,785.00 (357,603.33) $3,425,016.42 Current Allocation 13% 1% 11% EFTA01539689 17% US Small/Mid Cap Equity 42% Preferred Stocks Concentrated & Other Equity Asset Categories Equity as a percentage of your portfolio - 42 % Account Page 4 of 25 Consol

information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 130.75 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A1-A7-6 FACEBOOK INC-A 30303M-10-2 FB HSBC MARKET PLUS SPX 05/

d 106.10 2,000,000.000 2,122,000.00 2,000,000.00 122,000.00 US Small Cap Equity P EXTERRAN PARTNERS LP 23.65 COMMON UNITS 30225N-10-5 EXLP US Small/Mid Cap Equity DEUTSCHE BK AG LDN BRH DBL LONG ETN38 25154H-55-8 DAG Preferred Stocks BARCLAYS BANK PLC PFD SHS SER 5 8 1/8% 06739H-36-2 BCS PDAA /P-2 0.00

information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 116.47 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A1-A7-6 P FIRST REPUBLIC BANK SAN FRAN HSBC MARKET PLUS SPX 05

o - 34 % Change In Value (189,830.05) 151,500.00 737,667.50 (1,332,662.45) ($633,325.00) Current Allocation 17% 1% EFTA01539867 7% 9% US Small/Mid Cap Equity 34% Preferred Stocks Asset Categories US Large Cap Equity Account Page 4 of 28 Consolidated Statement Page 7 EFTA01539868 FINANCIAL TRUST C

information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 145.83 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A1-A7-6 FACEBOOK INC-A 30303M-10-2 FB GS CONT BUFF EQ SPX 7/9/